Prof. Chiara Riganti graduated in medicine at the University of Turin, Italy, in 2002, and obtained the specialization in clinical biochemistry at the University of Turin, Italy, in 2006. She worked as a visiting scientist at the Institute Cochin, INSERM, Paris, in 2010 and as a visiting professor at the Weizmann Institute of Science, Rehovot, Israel, in 2011 and 2013. She is currently an associate professor of biochemistry at the University of Turin, Italy. Her research focuses on the biochemical basis of multidrug resistance and immune resistance/immunotolerance in cancer cells, as well as the validation of multi-target chemo- and immunosensitizer drugs. She was awarded the “SIB medal” for young investigators (2005), the “AICC prize for senior investigators” (2011), and the “Outstanding Achievements in Oncology Award” (2017). She tied for the Gianni Bonadonna Prize for the “Development of New Drugs in Oncology” (2017).
